(Q44342075)

2 December 2017

title

Prognostic factors for survival in human immunodeficiency virus-associated pulmonary arterial hypertension (English)

1 reference

2 December 2017

2

Marc Humbert

1 reference

2 December 2017

12

Gérald Simonneau

1 reference

2 December 2017

8

Florence Parent

1 reference

2 December 2017

9

Gilles Garcia

1 reference

2 December 2017

3

Olivier Sitbon

1 reference

2 December 2017

11

Robyn J Barst

1 reference

2 December 2017

Hilario Nunes

1

1 reference

2 December 2017

Jane H Morse

4

1 reference

2 December 2017

Zemin Deng

5

1 reference

2 December 2017

James A Knowles

6

1 reference

2 December 2017

Catherine Le Gall

7

1 reference

2 December 2017

Philippe Hervé

10

1 reference

2 December 2017

language of work or name

English

0 references

publication date

25 February 2003

1 reference

American Journal of Respiratory and Critical Care Medicine

2 December 2017

published in

1 reference

2 December 2017

volume

167

1 reference

2 December 2017

issue

10

1 reference

2 December 2017

page(s)

1433-1439

1 reference

Primary pulmonary hypertension: a vascular biology and translational research "Work in progress".

2 December 2017

cites work

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200204-330OC

Primary pulmonary hypertension in HIV infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200204-330OC

Pulmonary hypertension in patients with human immunodeficiency virus infection. Comparison with primary pulmonary hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200204-330OC

HIV-associated primary pulmonary hypertension. A case control study. Swiss HIV Cohort Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200204-330OC

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200204-330OC

Risk factors for pulmonary arterial hypertension.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200204-330OC

Familial primary pulmonary hypertension (gene PPH1) is caused by mutations in the bone morphogenetic protein receptor-II gene

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200204-330OC

Heterozygous germline mutations in BMPR2, encoding a TGF-beta receptor, cause familial primary pulmonary hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200204-330OC

Sporadic primary pulmonary hypertension is associated with germline mutations of the gene encoding BMPR-II, a receptor member of the TGF-beta family

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200204-330OC

Declining morbidity and mortality among patients with advanced human immunodeficiency virus infection. HIV Outpatient Study Investigators

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200204-330OC

Changing patterns of mortality across Europe in patients infected with HIV-1. EuroSIDA Study Group.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200204-330OC

A comparison of continuous intravenous epoprostenol (prostacyclin) with conventional therapy for primary pulmonary hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200204-330OC

Reduction in pulmonary vascular resistance with long-term epoprostenol (prostacyclin) therapy in primary pulmonary hypertension.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200204-330OC

Epoprostenol (prostacyclin) therapy in HIV-associated pulmonary hypertension.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200204-330OC

Primary pulmonary hypertension. A national prospective study

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200204-330OC

Inhaled nitric oxide as a screening agent for safely identifying responders to oral calcium-channel blockers in primary pulmonary hypertension.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200204-330OC

Long-term intravenous epoprostenol infusion in primary pulmonary hypertension: prognostic factors and survival.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200204-330OC

The effect of high doses of calcium-channel blockers on survival in primary pulmonary hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200204-330OC

BMPR2 germline mutations in pulmonary hypertension associated with fenfluramine derivatives.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200204-330OC

New treatments for pulmonary arterial hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200204-330OC

Blind Analysis of Denaturing High-Performance Liquid Chromatography as a Tool for Mutation Detection

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200204-330OC

10.1164/RCCM.200204-330OC

21 January 2018

Identifiers

DOI

1 reference

2 December 2017

1 reference